Repare Therapeutics Inc. (NASDAQ: RPTX) Stock Information | RedChip
Image

ASK REDCHAT® ANYTHING ABOUT REPARE THERAPEUTICS INC.

Repare Therapeutics Inc. (NASDAQ: RPTX)
Listen to this Section


$1.25
+0.0550 ( +4.62% ) 54.9K

Repare Therapeutics Inc is a precision medicine oncology company focused on the development of synthetic lethality-based therapies for patients with cancer. The Company's focus is the research, development and commercialization of precision oncology drugs targeting specific vulnerabilities of tumors in genetically defined patient populations. The company derives maximum revenue from Canada.

Market Data


Open $1.25
Previous Close $1.19
Volume 54.9K
Market Cap $49.94M
Day Range $1.12 - $1.29
52 Week Range $1.10 - $8.49
Shares Outstanding 42.51M
Change % +4.62%
Net Change ▲ 0.0550
Insider Ownership N/A
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
IPO Year 2020
Country United States
Under Writer IPO Intelligence Only

Insider Ownership Transactions

Total Amount Purchased: 356,876.00

Date Type Amount Purchased Purchaser
2024-06-20 Sale -27200.00 SCHAFER CAROL
2024-06-20 Sale -27200.00 Morrison Briggs
2024-06-20 Sale -27200.00 Molineaux Susan
2024-06-20 Sale -27200.00 Kulkarni Samarth
2024-06-20 Sale -27200.00 Bonita David P
2024-06-20 Sale -27200.00 Civik Thomas
2024-06-20 Sale -54000.00 Stein Steven H
2024-06-20 Sale -27200.00 RHOADS ANN D
2024-04-01 Sale -2650.00 Segal Lloyd Mitchell
2024-04-01 Sale -825.00 Forte Steve

Institutional Ownership

Total Market Value $ 0.00

Symbol Issuer Name Market Value ↓ Share Quantity
No records found.

SEC Fillings


Form Type Description Pages Date
8-k 8K-related 63 Dec 12, 2024
10-q Quarterly Reports 66 Nov 07, 2024
8-k 8K-related 13 Nov 07, 2024
8-k 8K-related 16 Aug 28, 2024
8-k 8K-related 13 Aug 07, 2024
10-q Quarterly Reports 59 Aug 06, 2024
8-k 8K-related 13 Aug 06, 2024
4 Insider transactions 1 Jun 20, 2024
4 Insider transactions 1 Jun 20, 2024
4 Insider transactions 1 Jun 20, 2024

Latest News


× Before browsing our site, please accept our cookies policy